Most Popular
What’s in Store for Puma Biotechnology (PBYI) in Q1 Earnings?
We expect investors to focus on the sales performance of Puma Biotechnology, Inc.’s PBYI sole marketed drug, Nerlynx (neratinib), and updates related to its ...
Colgate (CL) Stock Up on Q1 Earnings & Sales Beat, Raised View
Colgate-Palmolive Company CL has reported first-quarter 2024 results, wherein the top and bottom lines beat the Zacks Consensus Estimate and improved year over year. ...
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
Edwards Lifesciences Corporation EW reported adjusted earnings per share (EPS) of 66 cents in first-quarter 2024, surpassing the Zacks Consensus Estimate by 3.1%. The ...
Federated Hermes (FHI) Q1 Earnings Meet, Expenses Rise Y/Y
Federated Hermes, Inc.’s FHI first-quarter 2024 earnings per share of 89 cents met the Zacks Consensus Estimate. The bottom line increased from 78 cents ...
How to Find Winning Stocks During Market Pullbacks
It’s been a solid start to the first-quarter earnings season. Still, despite the positive action today, the major U.S. indexes remain in the midst ...
Why Amazon (AMZN) Might Surprise This Earnings Season
Investors are always looking for stocks that are poised to beat at earnings season and Amazon.com, Inc. AMZN may be one such company. The ...












